SMTL ID : 6w07.1

Bruton's tyrosine kinase in complex with compound 1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.51 Å

Oligo State

monomer

Ligands

1 x S9A: ~{N}-[[2-methyl-4-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]phenyl]methyl]-3-propan-2-yloxy-azetidine-1-carboxamide(Non-covalent)

S9A.1: 19 residues within 4Å: Chain A: L.42, G.43, T.44, G.45, F.47, V.50, A.62, K.64, E.109, Y.110, M.111, A.112, G.114, N.160, L.162, D.173, S.177, V.180, Y.185 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.50, A:V.50, A:A.62, A:L.162, A:V.180, A:Y.185 Hydrogen bonds: A:M.111, A:M.111 Water bridges: A:G.45, A:Q.46, A:N.160

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 3 residues within 4Å: Chain A: S.283, L.286, D.287 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:D.287

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ma, B. et al., Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases. J.Med.Chem. (2020)

Release Date

2020-12-16

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence